Dr Obi Peter Adigwe is the new director general of the National Institute for Pharmaceutical Research and Development (NIPRD).
He graduated from the University of Jos, where he obtained his B.Pharm degree, before proceeding to obtain his postgraduate degrees from international institutions. Adigwe attended the University of Edinburgh, for his master’s degree in Global Health and Public Policy. He also studied at the University of Leeds, for his Doctor of Philosophy (PhD) in Global Health and Public Policy.
A scholar of international repute, Adigwe has, to his credit, a significant number of peer-reviewed publications, including the first K.A.P. study on Ebola in Nigeria. He had, while in the United Kingdom, co-authored a publication that influenced an epoch-making health policy reform in the British Parliament.
Adigwe has undertaken many national assignments. He has headed, as well as served on numerous committees and working groups at the highest levels. These include the the D-8 Organisation for Economij. , United Nations, World Health Organisation, African Union and the ECOWAS.
Prior to his appointment as the NIPRD DG, Adigwe was the executive secretary of the Pharmaceutical Manufacturers Group (PMG-MAN), where he played a key role in the development and implementation of policy initiatives, which made considerable impact in the pharmaceutical industry.
Some of his achievements in PMG-MAN include the prioritisation of the pharma industry in the 2016 Fiscal Policy, the organisation of the Landmark 2017 Pharma Expo, and his contributions to the conceptualisation of the internationally renowned Medicines’ Security Concept.
The NIPRD boss was also the pioneer Head of the Health Policy Research and Development (HPRD) Unit at the National Assembly, where he formulated research and development strategies in health policy as well as developed innovative and contextual training, research and capacity building modules.
He has also won several academic honours including the prestigious University of Leeds’ GRASS Postdoctorate award.
Pharmanews management and staff join other Nigerians to wish him a successful tenure.